In the following paragraphs, we will present the potential mechanisms of action of GLP-1RAs in NAFLD provided by studies in humans (Figure 3)
In both patient populations with pre-existing cardiovascular disease, DPP-4 inhibitors are recommended as one possible third-line therapy besides SGLT-2 inhibitors, thiazolidinediones, or insulin, when therapeutic goals are not met with the previous dual combination
Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, et al
MONDAY, April 27, 2026 (HealthDay News) Regaining the weight youve just lost is a major risk for anyone who decides to stop taking Ozempic or Zepbound
For patients, though, the experience is often crystal clear: When the noise goes quiet, everything else becomes easier
Category : Lyophilized Vial Research Use Only